__timestamp | Supernus Pharmaceuticals, Inc. | United Therapeutics Corporation |
---|---|---|
Wednesday, January 1, 2014 | 122045000 | 1288519000 |
Thursday, January 1, 2015 | 144427000 | 1465761000 |
Friday, January 1, 2016 | 215003000 | 1598800000 |
Sunday, January 1, 2017 | 302238000 | 1725300000 |
Monday, January 1, 2018 | 408897000 | 1627800000 |
Tuesday, January 1, 2019 | 392755000 | 1448800000 |
Wednesday, January 1, 2020 | 520397000 | 1483300000 |
Friday, January 1, 2021 | 579775000 | 1685500000 |
Saturday, January 1, 2022 | 667238000 | 1936300000 |
Sunday, January 1, 2023 | 607521000 | 2327500000 |
In pursuit of knowledge
In the competitive landscape of biopharmaceuticals, United Therapeutics Corporation and Supernus Pharmaceuticals, Inc. have showcased remarkable revenue trajectories over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed, with revenue peaking at approximately $2.3 billion in 2023, marking an impressive 80% increase from 2014. Meanwhile, Supernus Pharmaceuticals demonstrated a robust growth pattern, achieving a revenue increase of over 400% during the same period, reaching around $607 million in 2023.
United Therapeutics maintained a steady revenue stream, with a notable surge in 2023, reflecting strategic advancements and market expansion. Supernus Pharmaceuticals, though smaller in scale, exhibited a dynamic growth curve, particularly between 2016 and 2022, highlighting its aggressive market penetration and product innovation. This comparative analysis underscores the diverse strategies and market responses of these two industry leaders, offering valuable insights into their financial evolution.
Revenue Showdown: United Therapeutics Corporation vs Alkermes plc
United Therapeutics Corporation and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation or BioCryst Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Dr. Reddy's Laboratories Limited or Supernus Pharmaceuticals, Inc.
Revenue Insights: Catalent, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Ascendis Pharma A/S and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Ionis Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Revenue Showdown: PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Bausch Health Companies Inc. vs Supernus Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Showdown: HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?